Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteosarcoma, Advanced”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Not applicableUnknownNCT03919539
What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for
Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity
Peking University People's Hospital 40
Early research (Phase 1)Ended earlyNCT01491594
What this trial is testing

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Who this might be right for
Sarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue
Duke University 1
Early research (Phase 1)Study completedNCT00413075
What this trial is testing

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma
Valerio Therapeutics 121
Not applicableTemporarily Not AvailableNCT03842865
What this trial is testing

Expanded Access of Vigil in Solid Tumors

Who this might be right for
Solid TumorEwing SarcomaEwing's Tumor Metastatic+5 more
Gradalis, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT05019703
What this trial is testing

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Who this might be right for
Locally Advanced OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma+2 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00544778
What this trial is testing

Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma

Who this might be right for
Sarcoma
City of Hope Medical Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT07193550
What this trial is testing

Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Who this might be right for
Bone Sarcomas
M.D. Anderson Cancer Center 70
Early research (Phase 1)Study completedNCT01061840
What this trial is testing

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Who this might be right for
Ewings SarcomaNon Small Cell Lung CancerLiver Cancer
Gradalis, Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03778996
What this trial is testing

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

Who this might be right for
Sarcoma, EwingSarcoma
Sarcoma Oncology Research Center, LLC 31
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT00807261
What this trial is testing

Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy

Who this might be right for
Sarcoma
Asan Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06564272
What this trial is testing

KC1036 in Adolescents With Advanced Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Beijing Konruns Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Early research (Phase 1)Study completedNCT02736565
What this trial is testing

Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma

Who this might be right for
Ewing's SarcomaEwing Family of TumorsEwing's Tumor Metastatic+4 more
Gradalis, Inc. 7
Testing effectiveness (Phase 2)Temporarily pausedNCT04824352
What this trial is testing

Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, Drug
Peking University People's Hospital 44
Very early researchWithdrawnNCT04877587
What this trial is testing

Gemcitabine With Ascorbate Including Adolescents

Who this might be right for
Soft Tissue SarcomaBone SarcomaUnresectable Soft Tissue Sarcoma+3 more
David Dickens
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Not applicableUnknownNCT03582527
What this trial is testing

PD-L1 Expression in Advanced Osteosarcoma

Who this might be right for
ProgressionSurvival
Peking University People's Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04690725
What this trial is testing

TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss

Who this might be right for
Safety IssuesEfficacy, Self
Peking University People's Hospital 29
Next Page